These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37578778)

  • 1. Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial.
    Davis GM; Hughes MS; Brown SA; Sibayan J; Perez-Guzman MC; Stumpf M; Thompson Z; Basina M; Patel RM; Hester J; Abraham A; Ly TT; Chaney C; Tan M; Hsu L; Kollman C; Beck RW; Lal R; Buckingham B; Pasquel FJ
    Diabetes Technol Ther; 2023 Oct; 25(10):677-688. PubMed ID: 37578778
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy.
    Davis GM; Peters AL; Bode BW; Carlson AL; Dumais B; Vienneau TE; Huyett LM; Ly TT
    Diabetes Care; 2023 Apr; 46(4):742-750. PubMed ID: 36787903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C; Ditton G; Russell GB; Aloi J
    J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Trial of Assisted Hybrid Closed-Loop Therapy Versus Sensor-Augmented Pump Therapy in Pregnancy.
    Polsky S; Buschur E; Dungan K; Garcetti R; Nease E; Malecha E; Bartholomew A; Johnson C; Pyle L; Snell-Bergeon J
    Diabetes Technol Ther; 2024 Aug; 26(8):547-555. PubMed ID: 38386437
    [No Abstract]   [Full Text] [Related]  

  • 5. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
    Messer LH; Buckingham BA; Cogen F; Daniels M; Forlenza G; Jafri RZ; Mauras N; Muir A; Wadwa RP; White PC; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):712-725. PubMed ID: 36173237
    [No Abstract]   [Full Text] [Related]  

  • 6. Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy With Continuous Glucose Monitoring in Adults With Type 1 Diabetes and Suboptimal Glycemic Control: A Single-Center, Randomized, Crossover Study.
    Boughton CK; Hartnell S; Lakshman R; Nwokolo M; Wilinska ME; Ware J; Allen JM; Evans ML; Hovorka R
    Diabetes Care; 2023 Nov; 46(11):1916-1922. PubMed ID: 37616583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Glycemic Outcomes During the MiniMed
    Pihoker C; Shulman DI; Forlenza GP; Kaiserman KB; Sherr JL; Thrasher JR; Buckingham BA; Kipnes MS; Bode BW; Carlson AL; Lee SW; Latif K; Liljenquist DR; Slover RH; Dai Z; Niu F; Shin J; Jonkers RAM; Roy A; Grosman B; Vella M; Cordero TL; McVean J; Rhinehart AS; Vigersky RA;
    Diabetes Technol Ther; 2023 Nov; 25(11):755-764. PubMed ID: 37782145
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes.
    Sherwood JS; Castellanos LE; O'Connor MY; Balliro CA; Hillard MA; Gaston SG; Bartholomew R; Greaux E; Sabean A; Zheng H; Marchetti P; Uluer A; Sawicki GS; Neuringer I; El-Khatib FH; Damiano ER; Russell SJ; Putman MS
    Diabetes Care; 2024 Jan; 47(1):101-108. PubMed ID: 37874987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.
    Petrovski G; Dimitrovski C; Bogoev M; Milenkovic T; Ahmeti I; Bitovska I
    Diabetes Technol Ther; 2011 Nov; 13(11):1109-13. PubMed ID: 21751889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial.
    Ekhlaspour L; Raghinaru D; Forlenza GP; Isganaitis E; Kudva YC; Lam DW; Levister C; O'Malley G; Church MM; Lum JW; Buckingham B; Brown SA
    J Diabetes Sci Technol; 2023 Jul; 17(4):935-942. PubMed ID: 35473359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes.
    Forlenza GP; Buckingham BA; Brown SA; Bode BW; Levy CJ; Criego AB; Wadwa RP; Cobry EC; Slover RJ; Messer LH; Berget C; McCoy S; Ekhlaspour L; Kingman RS; Voelmle MK; Boyd J; O'Malley G; Grieme A; Kivilaid K; Kleve K; Dumais B; Vienneau T; Huyett LM; Lee JB; O'Connor J; Benjamin E; Ly TT
    Diabetes Technol Ther; 2021 Jun; 23(6):410-424. PubMed ID: 33325779
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial.
    Renard E; Joubert M; Villard O; Dreves B; Reznik Y; Farret A; Place J; Breton MD; Kovatchev BP;
    Diabetes Care; 2023 Dec; 46(12):2180-2187. PubMed ID: 37729080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes.
    Kruger D; Kass A; Lonier J; Pettus J; Raskin P; Salam M; Trikudanathan S; Zhou K; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):697-711. PubMed ID: 36173236
    [No Abstract]   [Full Text] [Related]  

  • 14. Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial.
    Reznik Y; Carvalho M; Fendri S; Prevost G; Chaillous L; Riveline JP; Hanaire H; Dubois S; Houéto P; Pasche H; Mianowska B; Renard E
    Diabetes Obes Metab; 2024 Feb; 26(2):622-630. PubMed ID: 37921083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
    Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies.
    Christiansen M; Bartee A; Lalonde A; Jones RE; Katz M; Wolpert H; Brazg R
    Diabetes Technol Ther; 2021 Mar; 23(3):187-194. PubMed ID: 32940537
    [No Abstract]   [Full Text] [Related]  

  • 18. How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System.
    Polonsky WH; Hood KK; Levy CJ; MacLeish SA; Hirsch IB; Brown SA; Bode BW; Carlson AL; Shah VN; Weinstock RS; Bhargava A; Jones TC; Aleppo G; Mehta SN; Laffel LM; Forlenza GP; Sherr JL; Huyett LM; Vienneau TE; Ly TT;
    Diabetes Res Clin Pract; 2022 Aug; 190():109998. PubMed ID: 35853530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study.
    Nørgaard K; Ranjan AG; Laugesen C; Tidemand KG; Green A; Selmer C; Svensson J; Andersen HU; Vistisen D; Carstensen B
    Diabetes Care; 2023 Nov; 46(11):1958-1964. PubMed ID: 37610784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections.
    McAuley SA; Vogrin S; Lee MH; Paldus B; Trawley S; de Bock MI; Abraham MB; Bach LA; Burt MG; Cohen ND; Colman PG; Davis EA; Hendrieckx C; Holmes-Walker DJ; Jenkins AJ; Kaye J; Keech AC; Kumareswaran K; MacIsaac RJ; McCallum RW; Sims CM; Speight J; Stranks SN; Sundararajan V; Ward GM; Jones TW; O'Neal DN;
    Diabetes Technol Ther; 2021 Jun; 23(6):460-466. PubMed ID: 33351699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.